Uterine cancer is the most commonly diagnosed gynaecologic malignancy and it is the sixth most common cancer affecting women worldwide. Recent data on uterine cancer suggests that there has been a constant surge in the incidence rates of uterine cancer. Some of the underlying reasons for this might be –
Increased use of tamoxifen due to a surge in breast cancer cases
The most common symptom of uterine cancer is abnormal vaginal bleeding. This can be bleeding between periods, bleeding after menopause, or bleeding heavier than usual. It usually starts as light bleeding with watery discharge which tends to get heavier with time.
9 out of 10 uterine cancer patients report this symptom. However, abnormal vaginal bleeding may also occur due to other issues. It is best to consult a gynecologist before reaching any conclusion.
The exact causes of uterine cancer are not yet known. However, through years of observation, study and research, a few factors have been revealed that play a crucial role in increasing the risk of cancer in the uterus.
Some of the risk factors leading to uterine cancer are controllable, like the use of hormone regulating medicines, obesity and diabetes. But most of the factors contributing to uterine cancer are beyond one’s control. Infertility, early menarche, ageing, hereditary risks are some of the natural causatives.
The risk of uterine cancer increases with aging. Most cases of uterine cancer occur in women aged 40 to 74. More than 50% of cases of uterine cancer are reported in women over the age of 55, while only 1% of cases are found in women under the age of 40.
It can be said that ageing is one of the major risk factors for uterine cancer. Hence, women should be more vigilant for bleeding or discharge post-menopause. It can be a signal of uterine cancer.
Women with obesity issues are two to four times more likely to develop uterine cancer than women of normal weight. Women who are very obese are 6 times more likely to develop uterine cancer than women of healthy weight.
This is mainly because the fat in the body can change other hormones into estrogen. And higher the level of estrogen hormones, greater the risk of developing uterine cancer. Obesity is also a well-known risk factor of diabetes which too increases the risk of uterine cancer.
About 5 per cent of uterine cancer is linked to hereditary factors. Hereditary plays an important role in the development of cancer. However, a family history of cancer does not necessarily mean that one would get cancer.
Familial history of cancer or Lynch syndrome may result in a high risk of endometrial cancer. Women with these conditions are at 70% increased risk of developing endometrial cancer.
Tamoxifen is a drug that is used in the treatment or prevention of breast cancer. It reduces the effect of estrogen in breast tissues but amplifies the estrogen impact in the uterus. This increases the risk of uterine cancer, especially in post-menopausal women.
However, the risk of developing uterine cancer from tamoxifen is low, less than 1% per year. Also, the benefits of tamoxifen in preventing breast cancer outweighs the risk.
But still, it is important to discuss the risks before using tamoxifen for breast cancer treatment. Women who use Tamoxifen should be more attentive to any abnormal vaginal bleeding. Also, a yearly gynaecologic examination is advised!
This is a natural risk factor for uterine cancer. Women who had an early puberty (before the age of 12) and late menopause (after the age of 50) are at an increased risk of uterine Cancer.
The more the number of menstrual cycles, the greater is the risk. Women who have frequent menstrual cycles (less than 28 days) or have a history of polycystic ovarian syndrome (PCOS) have the same risk.
This is because of the increased exposure to estrogen hormones during their lifetime. The hormone estrogen plays a key role in the regulation of menstrual cycles. More menstruation cycles mean higher lifetime exposure to estrogen which is a known risk for uterine cancer.
Researchers say that at least one pregnancy throughout the lifetime seems to reduce the risk of uterine cancer. This is because, during pregnancy, a woman’s body produces more progesterone and less estrogen.
Irregular mensuration cycles, infertility or no child by choice may cause an imbalance in estrogen and progesterone levels, which may increase the risk of uterine cancer.
Radiation therapy to the pelvic area for the treatment of a different type of cancer can increase a woman’s risk of uterine cancer. Radiation may damage the healthy cells in the uterus, thus leading to cancer of the uterus.
Retinoblastomais a type of eye cancer, usually caused by an abnormal gene. It is a common cancer diagnosed in children. However, in some cases, retinoblastoma can occur in adults too. Researchers have found that a history of retinoblastoma may be linked to a higher risk of uterine sarcoma.
A history of other health issues like high blood sugar, high blood pressure, high levels of triglycerides, low levels of high-density lipoproteins in the blood or extra fat around the abdomen is also cited as a risk factor for uterine cancer.
All of these risk factors increase the risk of developing uterine cancer in a lifetime by some percentage. But none of these factors can guarantee the development of uterine cancer. There are many people who have been exposed to one or more of these risk factors, but have not reported of cancer.
Most cases of uterine cancer are caused by natural factors that are beyond one’s control. But there are a few lifestyle factors like obesity, diabetes etc. can further alleviate the risk. So, controlling these factors can lower the risk of uterine cancer to some extent.
Here are a few tips advised by experts to prevent uterine cancer:
Staging of Uterine Cancer helps in proper diagnosis and planning for the treatment. It is staged in 4 levels ranging from stage I to IV, the severity increasing with each passed stage. The stages are discussed in details below:
Survival rate is a mere estimation calculated by taking into account the past records of uterine cancer patient’s survival. Usually, it is calculated for a period of 5 years. But these percentage should not be treated as a verdict. There are several factors that matter in determining the prognosis or survival rate of uterine cancer.
Here is the statistical data shared by researchers that can give a vague idea about the severity of the cancer at different stages:
Stage | Survival Rate |
0 | 90% |
IA | 88% |
IB | 75% |
II | 69% |
IIIA | 58% |
IIIB | 50% |
IIIC | 47% |
IVA | 17% |
IVB | 15% |
About 67% of uterine cancer cases are detected in an early stage. Because cancerous growth in the uterus often causes symptoms like vaginal bleeding, pelvic pain, vaginal discharge and discomfort.
Most cases of uterine cancer are diagnosed during a visit to the gynaecologist. In case the gynaecologist suspect cancer, he or she might suggest any of the following tests and screenings to confirm the presence of cancerous cells:
Uterine cancer in most cases are detected early and treated fairly. The treatment options for uterine cancer depend on multiple characteristics, like the stage, general health condition, root cause, age of the patient, their preference and many such factors. Weighing all the factors the oncologist could choose any of the following treatment options –
Uterine Cancer, if detected at early stages is easy to cure. Endometrial Cancer is usually cured with proper treatment while uterine sarcoma is harder to cure. Removing the uterus along with the surrounding affected organs is generally the go to solution, though it ends up in menopause and infertility.
Though cure at later stages become slim, but there is a great possibility of finding cure even after cancer has metastasized. The patient and healthcare team should work closely towards the progress of treatment.
Open conversations about the symptoms, side-effects, mental health, emotional conditions, coping and recovering helps in better prognosis.
People who have ticked on one or more of the risk factors should go for regular screenings and tests. Post-menopausal women, obese women, women with hormonal issues, women with frequent periods, women using tamoxifen or exposed to any other risks should consult a gynaecologist regularly with or without symptoms.
Women who in doubt for any of the symptoms should consult a gynecologist and get their doubts cleared. Even a faint or ignorable symptom could still be an early signal, which when attended could save a lot of damage.
Uterine Cancer is among those few cancer types that are usually detected early for the prominent symptoms it produces. Abnormal vaginal bleeding, vaginal discharge, pelvic pain, a tumorous mass, bloating often lead the patient to the doctor’s clinic resulting in diagnosis.